IMVT - Immunovant Inc (Healthcare: Biotechnology) Projected Earnings Date: 2025-02-06    (Delayed quote data   2025-01-03)
Last
 24.81		 Change
 ⇓ -0.38   (-1.51%)		 Volume
  487,955
Open
 24.52		 High
 25.52		 Low
 24.44
8EMA (Daily)
 25.17		 40EMA (Daily)
 27.06		 50EMA (Daily)
 27.36		 STO (Daily)
 14.854		 MACD Hist (Daily)
 -0.262
8EMA (Weekly)
 26.443		 40EMA (Weekly)
 28.72		 50EMA (Weekly)
 28.67		 STO (Weekly)
 18.641		 MACD Hist (Weekly)
 -0.990
Company Profile
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com